Trade

with

Imprimis Pharmaceuticals Inc
(NASDAQ: IMMY)
AdChoices
8.00
+0.10
+1.27%
After Hours :
8.00
0.00
0.00%

Open

7.93

Previous Close

7.90

Volume (Avg)

4.37k (24.31k)

Day's Range

7.73-8.00

52Wk Range

3.01-9.62

Market Cap.

73.04M

Dividend Rate ( Yield )

-

Beta

-1.28

Shares Outstanding

9.13M

P/E Ratio (EPS)

-

AdChoices
Fundamentals
  • Key statistics
  • Growth
  • Profitability
  • Financial health
  • Price ratios
  • Trading statistics
Industry Biotechnology
Highlights
Analyst Recommendation: Not Available
    • Revenue

    • 10.00k

    • Net Income

    • -7.64M

    • Market Cap.

    • 73.04M

    • Enterprise Value

    • -

    • Net Profit Margin %

    • -1,317.36

    • PEG (Price/Earnings Growth) Ratio

    • -

    • Beta

    • -1.28

    • Forward P/E

    • -

    • Price/Sales

    • 105.26

    • Price/Book Value

    • 5.99

    • Price/Cash flow

    • -12.33

      • EBITDA

      • -7.64M

      • Return on Capital %

      • -55.06

      • Return on Equity %

      • -60.59

      • Return on Assets %

      • -55.06

      • Book Value/Share

      • 1.32

      • Shares Outstanding

      • 9.13M

      • Last Split Factor (Date)

      • -

      • Last Dividend (Ex-Date)

      • -

      • Dividend Declaration Date

      • -

      Analyst Recommendation
      -
      Not Available
        • 1 Year Price Target

        • -

        • Credit Rating

        • -

        • Analysts

        • 0

        • EPS Estimate

        • -

        • Cashflow Estimate

        • -

        Morningstar Consensus estimate data
        • Growth Rate (%)

        • Company

        • Industry

          • Sales (Revenue)

            Q/Q (last year)

          • -43.60

          • 40.73

          • Net Income

            YTD/YTD (last year)

          • -

          • 17.04

          • Net Income

            Q/Q (last year)

          • -

          • 98.90

          • Sales (Revenue)

            5-Year Annual Average

          • -

          • 63.43

          • Net Income

            5-Year Annual Average

          • -

          • 10.65

          • Dividends

            5-Year Annual Average

          • -

          • 15.81

          • Profit Margins (%)

          • Company

          • Industry

            • Gross Margin

            • 29.31

            • 82.75

            • Pre-Tax Margin

            • -1,317.36

            • 39.38

            • Net Profit Margin

            • -1,317.36

            • 31.33

            • Average Gross Margin

              5-Year Annual Average

            • -

            • 82.99

            • Average Pre-Tax Margin

              5-Year Annual Average

            • -

            • 33.42

            • Average Net Profit Margin

              5-Year Annual Average

            • -

            • 199.05B

            • Financial Ratios

            • Company

            • Industry

              • Debt/Equity Ratio

              • 0.00

              • 0.76

              • Current Ratio

              • 9.56

              • 2.92

              • Quick Ratio

              • 9.19

              • 2.35

              • Interest Coverage

              • -5,673.43

              • 38.02

              • Leverage Ratio

              • 1.15

              • 2.21

              • Book Value/Share

              • 1.32

              • 4.75

              • Price Ratios

              • Company

              • Industry

                • Current P/E Ratio

                • -7.76

                • 277.78

                • P/E Ratio 5-Year High

                • -75.13

                • 634.30

                • P/E Ratio 5-Year Low

                • -0.51

                • 124.82

                • Price/Sales Ratio

                • 102.04

                • 9.35

                • Price/Book Value

                • 5.79

                • 8.50

                • Price/Cash Flow Ratio

                • -12.33

                • 50.25

                • Key Metrics

                • Company

                • Industry

                  • Return on Equity %

                    (5-Year Average)

                  • -60.59

                    (-)

                  • 37.63

                    (27.20)

                  • Return on Assets %

                    (5-Year Average)

                  • -55.06

                    (-190.20)

                  • 17.22

                    (13.81)

                  • Return on Capital %

                    (5-Year Average)

                  • -60.51

                    (-)

                  • 21.78

                    (17.31)

                  • Income/Employee

                  • -

                  • 117.08k

                  • Inventory Turnover

                  • 2.76

                  • 1.48

                  • Asset Turnover

                  • 0.04

                  • 0.55

                  Current Historical
                  Financials
                  • Income Statement
                  • Balance Sheet
                  • Cash Flow
                  Operating Income
                  -7.69M
                  Operating Margin
                  -76,868.79
                  Total Equity
                  -
                  Retained Earnings
                  -
                  Free Cashflow
                  -
                  Price/Cashflow
                  -12.33
                  Ownership

                  Institutional Ownership

                  20.54%

                  Top 10 Institutions

                  20.40%

                  Mutual Fund Ownership

                  1.26%

                  Float

                  74.82%

                  5% / Insider Ownership

                  54.51%

                  Corporate insiders or major stockholders reporting trading activity in the stock.

                  Top Mutual Fund Owners

                  Top Institutional Owners

                  Mutual Fund Name

                  Institution Name

                  • Mutual Fund Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • Vanguard Total Stock Mkt Idx

                  •  

                    75,879

                  • 0.00

                  • 0.83

                  • iShares Micro-Cap

                  •  

                    18,094

                  • 1.28

                  • 0.21

                  • Vanguard Extended Market Index Fund

                  •  

                    11,791

                  • 0.00

                  • 0.13

                  • Fidelity® NASDAQ Composite Index® Fund

                  •  

                    2,451

                  • 0.00

                  • 0.03

                  • AXA/Lord Abbett Micro Cap Portfolio

                  •  

                    1,162

                  • 0.00

                  • 0.01

                  • Fidelity® Nasdaq Composite Tr Stk Fund

                  •  

                    1,093

                  • 9.41

                  • 0.01

                  • Institution Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • Bard Associates Inc

                  •  

                    111,053

                  • 0.00%

                  • 1.22

                  • Vanguard Group, Inc.

                  •  

                    86,373

                  • +9.74%

                  • 0.95

                  • Revelation Capital Management Ltd

                  •  

                    80,500

                  • -14.81%

                  • 0.88

                  • Columbia Management Company

                  •  

                    75,949

                  • 0.00%

                  • 0.83

                  • Regions Financial Corp

                  •  

                    30,500

                  • 0.00%

                  • 0.33

                  • Marathon Capital Management LLC

                  •  

                    25,000

                  • 0.00%

                  • 0.27

                  Company Profile

                  Sector

                  Healthcare

                  Industry

                  Biotechnology

                  Type

                  Distressed

                  Style

                  Small Growth

                  Imprimis Pharmaceuticals Inc is a development stage pharmaceutical company.

                  Key People

                  Mark L. Baum

                  CEO/Director

                  Dr. Robert J. Kammer

                  Chairman of the Board/Director

                  Mr. Andrew R. Boll

                  CFO/Chief Accounting Officer/Vice President, Divisional

                  Mr. William H. Nelson, Jr

                  Director

                  Mr. Steven G. Austin

                  Director

                  • Imprimis Pharmaceuticals Inc

                  • 12626 High Bluff Drive

                  • San Diego, CA 92130

                  • USA.Map

                  • Phone: +1 858 704-4040

                  • Fax: +1 858 345-1745

                  • imprimispharma.com

                  Incorporated

                  1998

                  Employees

                  17

                  Send Feedback

                  We appreciate your input!

                  • I'm having trouble signing into my Microsoft account

                  • I’m having problems with the services stripe (Mail, Facebook, etc.)

                  • There is an issue with my weather information

                  • I see an error in the content

                  • Other

                  Please give an overall site rating: